circulatory
disorders research fund
A newly
established fund to promote research into circulatory disorders
related to atherosclerosis
- its
related risk factors
- and
complications.
Funds of
up to R1,000,000 are available to research units or individuals
in 2004.
Any original
clinical, basic science or epidemiological research related
to atherosclerosis will be considered.
Applications
Can be made twice in 2004 with the following closing dates:
1 March for July 2004 awards
AND
1 August for December 2004 awards.
The
CDRF is an unique collaboration between these Founding Members:
- Lipid
and Atherosclerosis Society of South Africa (LASSA)
- National
Kidney Foundation of South Africa
- Society
for Endocrinology, Metabolism and Diabetes of South Africa
(SEMDSA)
- South
African Heart Association
- South
African Renal Society
- Southern
African Hypertension Society
- Southern
African Stroke Foundation
- Vascular
Society of Southern Africa (VASSA)
Donors
- AstraZeneca
- Aventis
- Boehringer
Ingelheim
- Merck
- MSD
- Netcare
- Novartis
- Pfizer
- Roche
- Sanofi-Synthelabo
- Servier
Laboratories
- Solvay
Pharma
The Founding
Members have made contributions from their Society Funds |
